Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00776 | 34971806 | Clin Gastroenterol Hepatol | Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population. | 2021 | Details |
| A00777 | 34971370 | J Clin Endocrinol Metab | Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00780 | 34969770 | Anticancer Res | Development of Non-alcoholic Steatohepatitis and Nodular Regenerative Hyperplasia in C57BL/6J Mice Fed a Fructose-containing Western Diet. | 2022 | Details |
| A00781 | 34967286 | Mini Rev Med Chem | Dietary Intake of Hydrolyzable Tannins and Condensed Tannins to Regulate Lipid Metabolism. | 2021 | Details |
| A00791 | 34966134 | Eur J Gastroenterol Hepatol | Prospective screening for significant liver fibrosis by fibrosis-4 in primary care patients without known liver disease. | 2021 | Details |
| A00796 | 34964438 | Elife | Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing PPARA. | 2021 | Details |
| A00798 | 34962148 | Metab Syndr Relat Disord | PNPLA3 rs 738409 and Other Nongenetic Factors Associated with Hepatic Steatosis Estimated by Magnetic Resonance Imaging Proton Density Fat Fraction in Adult Greek Subjects with Type 2 Diabetes Mellitus. | 2021 | Details |
| A00799 | 34962146 | Metab Syndr Relat Disord | Prevalence of Hepatic Steatosis and Fibrosis in the United States. | 2021 | Details |
| A00805 | 34959901 | Nutrients | Role and Treatment of Insulin Resistance in Patients with Chronic Kidney Disease: A Review. | 2021 | Details |
| A00808 | 34959747 | Nutrients | High-Fructose, High-Fat Diet Alters Muscle Composition and Fuel Utilization in a Juvenile Iberian Pig Model of Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00811 | 34959119 | Biomed Pharmacother | GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease. | 2021 | Details |
| A00818 | 34957498 | Diabetes | Hepatic CPT1A Facilitates Liver-Adipose Cross-Talk via Induction of FGF21 in Mice. | 2021 | Details |
| A00819 | 34957487 | Diabetes | Active Brown Adipose Tissue is Associated With a Healthier Metabolic Phenotype in Obesity. | 2021 | Details |
| A00825 | 34956171 | Front Immunol | Hepatic Macrophage as a Key Player in Fatty Liver Disease. | 2021 | Details |
| A00837 | 34952219 | Endocr Pract | Fatty Liver Through the Ages: Nonalcoholic Steatohepatitis. | 2021 | Details |
| A00842 | 34950996 | Indian J Gastroenterol | Fetuin-A in newly detected type 2 diabetes mellitus as a marker of non-alcoholic fatty liver disease. | 2021 | Details |
| A00844 | 34950780 | JGH Open | Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study. | 2021 | Details |
| A00850 | 34948230 | Int J Mol Sci | It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them? | 2021 | Details |
| A00857 | 34945016 | J Clin Med | Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review. | 2021 | Details |
| A00860 | 34944730 | Biomedicines | Metabolic Fatty Liver Disease in Children: A Growing Public Health Problem. | 2021 | Details |
| A00863 | 34944709 | Biomedicines | Diet and Gut Microbiota Interaction-Derived Metabolites and Intrahepatic Immune Response in NAFLD Development and Treatment. | 2021 | Details |
| A00865 | 34944682 | Biomedicines | Metabolic Associated Fatty Liver Disease in Children-From Atomistic to Holistic. | 2021 | Details |
| A00866 | 34944668 | Biomedicines | The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease. | 2021 | Details |
| A00869 | 34944525 | Biomolecules | A System-Level Mechanism of Anmyungambi Decoction for Obesity: A Network Pharmacological Approach. | 2021 | Details |
| A00872 | 34943946 | Cells | Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese Ay Mice. | 2021 | Details |
| A00873 | 34943942 | Cells | MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in Gender-Disparity Hepatocarcinogenesis. | 2021 | Details |
| A00876 | 34943809 | Cells | Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00881 | 34943104 | Antioxidants (Basel) | The Synbiotic Combination of Akkermansia muciniphila and Quercetin Ameliorates Early Obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation. | 2021 | Details |
| A00883 | 34942625 | Dig Dis | Clinical profiles of Asians with NAFLD: A systematic review and meta-analysis. | 2021 | Details |
| A00884 | 34942286 | J Hepatol | Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease. | 2021 | Details |
| A00885 | 34941988 | J Gastrointestin Liver Dis | The Role of Psychotherapy in the Treatment of Patients with Non- alcoholic Fatty Liver Disease and Obstructive Sleep Apnea. | 2021 | Details |
| A00888 | 34940698 | Mar Drugs | Soluble Polysaccharide Derived from Laminaria japonica Attenuates Obesity-Related Nonalcoholic Fatty Liver Disease Associated with Gut Microbiota Regulation. | 2021 | Details |
| A00895 | 34938205 | Front Physiol | Ectodysplasin A/Ectodysplasin A Receptor System and Their Roles in Multiple Diseases. | 2021 | Details |
| A00898 | 34935645 | JCI Insight | Maternal Western diet exposure increases periportal fibrosis beginning in utero in nonhuman primate offspring. | 2021 | Details |
| A00900 | 34935140 | Br J Pharmacol | Mineralocorticoid receptors in non-alcoholic fatty liver disease. | 2022 | Details |
| A00901 | 34934197 | Acta Pharmacol Sin | GLP-1 mimetics as a potential therapy for nonalcoholic steatohepatitis. | 2021 | Details |
| A00916 | 34931080 | Nat Metab | Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. | 2021 | Details |
| A00934 | 34924365 | J Obes Metab Syndr | Severe Obesity in Children and Adolescents: Metabolic Effects, Assessment, and Treatment. | 2021 | Details |
| A00935 | 34924319 | Dig Liver Dis | Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). | 2021 | Details |
| A00936 | 34924246 | Nutr Metab Cardiovasc Dis | Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). | 2021 | Details |
| A00939 | 34923473 | Wiad Lek | FEASIBILITY OF CYSTATIN C DETERMINATION FOR EARLY DIAGNOSIS OF KIDNEY DAMAGE IN PATIENTS WITH TYPE 2 DIABETES COMBINED WITH NONALCOHOLIC FATTY LIVER DISEASE AND OBESITY EXPOSED TO COVID-19 INFECTION IN THE PAST. | 2021 | Details |
| A00946 | 34922604 | Trials | Omega-3 mechanism of action in inflammation and endoplasmic reticulum stress in mononuclear cells from overweight non-alcoholic fatty liver disease participants: study protocol for the "Brazilian Omega Study" (BROS)-a randomized controlled trial. | 2021 | Details |
| A00955 | 34920070 | Int J Biol Macromol | MDG, an Ophiopogon japonicus polysaccharide, inhibits non-alcoholic fatty liver disease by regulating the abundance of Akkermansia muciniphila. | 2021 | Details |
| A00956 | 34919684 | J Nutr | A Specifically Tailored Multistrain Probiotic and Micronutrient Mixture Affects Nonalcoholic Fatty Liver Disease-Related Markers in Patients with Obesity after Mini Gastric Bypass Surgery. | 2022 | Details |
| A00958 | 34919135 | JAMA Netw Open | Intermittent Fasting and Obesity-Related Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials. | 2021 | Details |
| A00959 | 34918671 | Medicine (Baltimore) | Clinical and sociodemographic determinants of disease progression in patients with nonalcoholic steatohepatitis in the United States. | 2021 | Details |
| A00960 | 34918493 | Pediatr Obes | MicroRNAs as the promising markers of comorbidities in childhood obesity-A systematic review. | 2021 | Details |
| A00963 | 34917917 | Metabol Open | Emerging roles for stress kinase p38 and stress hormone fibroblast growth factor 21 in NAFLD development. | 2021 | Details |
| A00968 | 34916558 | Sci Rep | A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight. | 2021 | Details |
| A00972 | 34915036 | Metabolism | Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers. | 2021 | Details |
| A00975 | 34914079 | Eat Weight Disord | Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). | 2021 | Details |
| A00976 | 34914039 | Indian J Gastroenterol | Endoscopic sleeve gastroplasty - minimally invasive treatment for non-alcoholic fatty liver disease and obesity. | 2021 | Details |
| A00977 | 34912244 | Front Physiol | Translational Control in Liver Disease. | 2021 | Details |
| A00991 | 34907907 | J Clin Invest | Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease. | 2021 | Details |
| A00992 | 34907906 | J Clin Invest | Dietary sugar restriction reduces hepatic de novo lipogenesis in boys with fatty liver disease. | 2021 | Details |
| A00993 | 34907642 | J Cell Mol Med | Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma. | 2021 | Details |
| A00998 | 34906902 | Biochem Biophys Res Commun | Obesity induced Ext1 reduction mediates the occurrence of NAFLD. | 2021 | Details |
| A01002 | 34905320 | Rev Med Inst Mex Seguro Soc | [Detecting non-alcoholic fatty liver in children with owerweight and obesity.] | 2021 | Details |
| A01003 | 34905051 | J Clin Endocrinol Metab | Fibrogenesis marker PRO-C3 is higher in advanced liver fibrosis and improves in patients undergoing bariatric surgery. | 2022 | Details |
| A01004 | 34904966 | Am J Gastroenterol | Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study. | 2022 | Details |
| A01010 | 34904028 | World J Hepatol | Liver involvement in inflammatory bowel disease: What should the clinician know? | 2021 | Details |
| A01016 | 34902629 | Cell Mol Gastroenterol Hepatol | Escherichia fergusonii Promotes Nonobese Nonalcoholic Fatty Liver Disease by Interfering With Host Hepatic Lipid Metabolism Through Its Own msRNA 23487. | 2021 | Details |
| A01017 | 34902220 | J Dig Dis | The importance and impact of recognizing metabolic dysfunction-associated fatty liver disease in patients with chronic hepatitis C. | 2022 | Details |
| A01018 | 34902008 | Am J Clin Nutr | Adiposity, metabolomic biomarkers, and risk of nonalcoholic fatty liver disease: a case-cohort study. | 2022 | Details |
| A01020 | 34901236 | Front Cardiovasc Med | Statins in Non-alcoholic Steatohepatitis. | 2021 | Details |
| A01023 | 34900782 | J Diabetes Metab Disord | Association and interaction between vitamin D level and metabolic syndrome for non-alcoholic fatty liver disease. | 2021 | Details |
| A01026 | 34899591 | Front Endocrinol (Lausanne) | Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease. | 2021 | Details |
| A01028 | 34898613 | PLoS One | The association between Helicobacter pylori with nonalcoholic fatty liver disease assessed by controlled attenuation parameter and other metabolic factors. | 2021 | Details |
| A01030 | 34896638 | Ann Hepatol | Laparoscopic cholecystectomy: Histopathological analysis of metabolic associated fatty liver disease and fibrosis. | 2021 | Details |
| A01032 | 34895743 | J Hepatol | The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? | 2021 | Details |
| A01038 | 34894060 | Liver Int | Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non-alcoholic fatty liver disease. | 2022 | Details |
| A01039 | 34894052 | Liver Int | Associations of liver volume and other markers of hepatic steatosis with all-cause mortality in the general population. | 2021 | Details |
| A01042 | 34893351 | Trends Pharmacol Sci | ER stress in obesity pathogenesis and management. | 2021 | Details |
| A01044 | 34890795 | Clin Gastroenterol Hepatol | 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. | 2021 | Details |
| A01045 | 34890093 | Liver Int | Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery. | 2021 | Details |
| A01047 | 34890043 | Eur J Clin Invest | The advantages of physical exercise as a preventive strategy against NAFLD in postmenopausal women. | 2022 | Details |
| A01053 | 34887631 | World J Gastroenterol | Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach. | 2021 | Details |
| A01054 | 34886991 | J Comp Pathol | Role of Plin5 Deficiency in Progression of Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice. | 2021 | Details |
| A01055 | 34886772 | Curr Alzheimer Res | Metabolic Syndrome, Alzheimer's Disease, and Covid 19: A Possible Correlation. | 2021 | Details |
| A01059 | 34884755 | Int J Mol Sci | Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity. | 2021 | Details |
| A01060 | 34884650 | Int J Mol Sci | Verification of the Impact of Blood Glucose Level on Liver Carcinogenesis and the Efficacy of a Dietary Intervention in a Spontaneous Metabolic Syndrome Model. | 2021 | Details |
| A01063 | 34883157 | J Hepatol | Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A01067 | 34881510 | Pediatr Obes | The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non-alcoholic fatty liver disease: A randomized controlled trial. | 2021 | Details |
| A01068 | 34881283 | Front Nutr | Caffeine and EGCG Alleviate High-Trans Fatty Acid and High-Carbohydrate Diet-Induced NASH in Mice: Commonality and Specificity. | 2021 | Details |
| A01072 | 34878523 | Endocrinology | Adipose-specific VDR Deletion Leads to Hepatic Steatosis in Female Mice Fed a Low-Fat Diet. | 2022 | Details |
| A01073 | 34878418 | Curr Opin Anaesthesiol | Preoperative evaluation of geriatric patients undergoing liver transplantation. | 2022 | Details |
| A01075 | 34877270 | World J Clin Cases | Pharmaconutrition strategy to resolve SARS-CoV-2-induced inflammatory cytokine storm in non-alcoholic fatty liver disease: Omega-3 long-chain polyunsaturated fatty acids. | 2021 | Details |
| A01083 | 34873855 | Clin Obes | Risk and protective factors of non-alcoholic fatty liver disease in paediatric obesity: A nationwide nested case-control study. | 2021 | Details |
| A01090 | 34871812 | Clin Gastroenterol Hepatol | Intensive Lifestyle Management Improves Steatosis and Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01097 | 34870138 | Metabol Open | Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD). | 2021 | Details |
| A01101 | 34869521 | Front Nutr | Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A01107 | 34867384 | Front Pharmacol | Effects of Nigella sativa, Camellia sinensis, and Allium sativum as Food Additives on Metabolic Disorders, a Literature Review. | 2021 | Details |
| A01114 | 34866842 | J Clin Exp Hepatol | Adipocytokines as Risk Factors for Development of Nonalcoholic Fatty Liver Disease in Children. | 2021 | Details |
| A01117 | 34864598 | Int J Hyg Environ Health | Exposure to polycyclic aromatic hydrocarbons and volatile organic compounds is associated with a risk of obesity and diabetes mellitus among Korean adults: Korean National Environmental Health Survey (KoNEHS) 2015-2017. | 2021 | Details |
| A01118 | 34863942 | Mol Metab | The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease. | 2021 | Details |
| A01119 | 34863940 | Mol Metab | URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice. | 2021 | Details |
| A01131 | 34860705 | Eur J Gastroenterol Hepatol | Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial. | 2022 | Details |
| A01133 | 34860208 | J Occup Environ Med | Determination of Cardiovascular Risk in 56,262 Spanish Construction Workers: Cardiovascular Risk in Construction Workers. | 2021 | Details |
| A01135 | 34859497 | J Gastroenterol Hepatol | Low serum pancreatic amylase levels as a novel latent risk factor for colorectal adenoma in non-alcohol drinkers. | 2021 | Details |
| A01138 | 34858322 | Front Endocrinol (Lausanne) | The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review. | 2021 | Details |